Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution

Name	Symbol	Market	Type
ProShares Global Listed Private Equity	AMEX:PEX	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

ProShares Global Listed Private Equity

AMEX:PEX

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.252	0.87%	29.087	29.1329	28.91	29.00	662	18:00:03

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

0.252

0.87%

29.087

29.1329

28.91

29.00

662

18:00:03

Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution

07/05/2009 3:30pm

PR Newswire (US)

ProShares Global Listed ... (AMEX:PEX)
Historical Stock Chart

From Dec 2019 to Dec 2024

Click Here for more ProShares Global Listed ... Charts.

HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) ("Apex") announced today that a special meeting of stockholders will be held at 10:00 a.m. local time on Tuesday, June 2, 2009, at the offices of Mintz Levin Cohn Ferris Glovsky & Popeo, P.C., located at 666 Third Avenue, New York, NY 10017. At the special meeting, Apex's stockholders will be asked to consider and vote on a plan of liquidation and dissolution of Apex. Stockholders of record as of the close of business on May 15, 2009 will be entitled to vote at the special meeting. Additional Information and Where to Find It This press release is not a proxy statement or a solicitation of proxies from Apex's stockholders. Any solicitation of proxies will be made only by the definitive proxy statement of Apex that will be mailed to all stockholders. Stockholders of Apex and other interested persons are advised to read Apex's preliminary proxy statement and definitive proxy statement, when available, in connection with Apex's solicitation of proxies for the special meeting because these proxy statements will contain important information about Apex and the proposed dissolution. Apex's preliminary proxy statement is available from the SEC's website at http://www.sec.gov/. The definitive proxy statement will be mailed to stockholders of record as of the close of business on May 15, 2009. Apex and its directors and officers may be deemed to be participants in the solicitation of Apex's stockholders in connection with the proposed liquidation and other matters with respect to which the company's stockholders will be asked to vote pursuant to the proxy statement. Information regarding the names, affiliations and interests of such individuals is contained in Apex's prospectus dated June 6, 2007 and the preliminary proxy statement and will be contained in the definitive proxy statement when it becomes available. Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements are based on current expectations and are subject to numerous risks, assumptions and uncertainties, many of which change over time and are beyond Apex's control. Actual results may differ materially from those anticipated in any forward-looking statement and you should not place any undue reliance on such forward-looking statements. More detailed information about Apex and risk factors that may affect the realization of forward-looking statements, including forward-looking statements in this press release, is set forth in Apex's filings with the Securities and Exchange Commission. Apex urges investors and security holders to read those documents free of charge at the Commission's web site at http://www.sec.gov/. Interested parties may also obtain these documents free of charge from Apex. Forward-looking statements speak only as to the date they are made, and except for any obligation under the U.S. federal securities laws, Apex undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise. DATASOURCE: Apex Bioventures Acquisition Corp. CONTACT: Darrell J. Elliott, Chairman and Chief Executive Officer, +1-604-924-0349, or K. Michael Forrest, President and Chief Operating Officer, +1-650-344-3029, both of Apex Bioventures Acquisition Corporation

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
FTSE Indices
Euronext
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Forex
Precious Metal

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
FTSE Indices
Euronext
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Forex
Precious Metal

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

PEX ProShares Global Listed Private Equity